Sevoflurane Bostonbio
NDC Package 72163-005-25

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Sevoflurane Bostonbio is a . Marketed by Boston Biopharma, this product is identified by NDC 72163-005 and is authorized under FDA application ANDA078650.

Identification & Billing

NDC Package Code
72163-005-25
Package Description
250 mL in 1 BOTTLE, GLASS
Product Code
72163-005
11-Digit Billing Format
72163000525
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Sevoflurane Bostonbio
Dosage Form
-

Regulatory & Marketing

Labeler Name
Boston Biopharma
FDA Application #
ANDA078650
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
03-27-2020
Listing Expiration
12-31-2021
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72163-005-25 identifies a specific commercial package of 250 ml in 1 bottle, glass of Sevoflurane Bostonbio, labeled by Boston Biopharma. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Boston Biopharma on March 27, 2020. The current certification is valid through December 31, 2021.

How is this Boston Biopharma product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72163000525. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72163-005-25
11-Digit CMS (5-4-2)
72163-0005-25

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.